Tumescent Lidocaine Maximum Safe mg/kg Dosage

• Status: Unknown status
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

This pharmacokinetic clinical trial is a dose ranging study of lidocaine in tumescent local anesthesia. The goal is to understand the absorption pharmacokinetic of tumescent lidocaine and to determine an objective (statistical) estimate of the maximum safe mg/kg dosage of lidocaine in tumescent local anesthesia without liposuction.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Klein, Jeffrey A., M.D.
• Treatments: Anesthetics; Epinephrine; Epinephryl borate; Lidocaine; Racepinephrine

Criteria

Inclusion Criteria:

• Healthy female (ASA class 1 or 2)

• Desires liposuction

• Easily accessible veins

Exclusion Criteria:

• History of Hepatitis C, HIV

• ASA class greater or equal to 3